PerpEquitiesTop analysts on stock perps · Analyst
Geoff Meacham (Citi): analyst track record on stock perps
Geoff Meacham of Citi on companies with stock perpetual futures: star rating, success rate, price-target accuracy, current calls and the measured perp reaction after each rating.
Stars4.8★
Success59%
Excess return+16.2%
rank#391
Ratings479
ratings on stock perps442
Track record
TipRanks data via FMP| 12 months | 3 years | |
|---|---|---|
| Ratings | 265 | 588 |
| Stock | 46 | 61 |
| Buy / hold / sell | 151 / 108 / 6 | 332 / 239 / 17 |
| Upgrades / downgrades / initiations | 0 / 3 / 5 | 2 / 8 / 24 |
| Price targets hit / missed | 140 / 118 (54%) | 345 / 213 (62%) |
| Avg. return after a rating (TipRanks) | +15.9% | +24.6% |
| Best / worst call | +387.9% / -73.6% | +816.9% / -95.2% |
After buy calls: median 21-day move +1.8% · vs S&P 500 +0.1% · targets hit within a year 51% (n = 397)
Current calls on stock perps
| Stock | Call | Target | vs last close | Date |
|---|---|---|---|---|
| $AMGN Amgen Inc. | Hold · Maintained | $405 | +5.9% | Sep 9, 2026 |
| $ABBV AbbVie Inc. | Hold · Maintained | $260 | +2.0% | Sep 4, 2026 |
| $VRTX Vertex Pharmaceuticals | Buy · Maintained | $585 | +13.7% | Sep 2, 2026 |
| $LLY Eli Lilly and Company | Buy · Maintained | $1,600 | +42.5% | Sep 1, 2026 |
| $BNTX BioNTech SE | Buy · Reiterated | $125 | +29.7% | Aug 31, 2026 |
| $MRNA Moderna, Inc. | Hold · Maintained | $60.00 | -56.1% | Aug 19, 2026 |
| $BMY Bristol Myers Squibb | Hold · Maintained | $70.00 | +9.8% | Aug 14, 2026 |
| $PFE Pfizer Inc. | Hold · Maintained | – | – | Aug 5, 2026 |
| $GILD Gilead Sciences, Inc. | Buy · Reiterated | $165 | +13.9% | Aug 4, 2026 |
| $BIIB Biogen Inc. | Hold · Maintained | $215 | -0.2% | Aug 3, 2026 |
| $REGN Regeneron Pharmaceuticals, Inc. | Hold · Maintained | $740 | -6.7% | Aug 3, 2026 |
| $MRK Merck & Co., Inc. | Hold · Maintained | $125 | -13.6% | Jul 15, 2026 |
Recent ratings
- Sep 9, 2026 $AMGN: Maintained · Hold · $405 · article
- Sep 4, 2026 $ABBV: Maintained · Hold · $260 · article
- Sep 2, 2026 $VRTX: Maintained · Buy · $585 · article
- Sep 1, 2026 $LLY: Maintained · Buy · $1,600 · article
- Aug 31, 2026 $BNTX: Reiterated · Buy · $125 · article
- Aug 19, 2026 $MRNA: Maintained · Hold · $60.00 · article
- Aug 14, 2026 $BMY: Maintained · Hold · $70.00 · article
- Aug 10, 2026 $AMGN: Maintained · Hold · $405 · article
- Aug 5, 2026 $PFE: Maintained · Hold · article
- Aug 5, 2026 $BNTX: Maintained · Buy · $125 · article
- Aug 5, 2026 $AMGN: Maintained · Hold · $345 · article
- Aug 4, 2026 $GILD: Reiterated · Buy · $165 · article
- Aug 3, 2026 $BIIB: Maintained · Hold · $215 · article
- Aug 3, 2026 $BMY: Maintained · Hold · $70.00 · article
- Aug 3, 2026 $MRNA: Maintained · Hold · $60.00 · article
- Aug 3, 2026 $REGN: Maintained · Hold · $740 · article
- Jul 29, 2026 $BIIB: Maintained · Hold · $200 · article
- Jul 15, 2026 $GILD: Maintained · Buy · $165 · article
- Jul 15, 2026 $MRK: Maintained · Hold · $125 · article
- Jul 15, 2026 $PFE: Maintained · Hold · $27.00 · article
Geoff Meacham4.8★ · 59% success · +16.2% excess return · TipRanks data via FMP · Source headlines via TheFly/StreetInsider (FMP). Reaction = venue-median perp move after our detection — an observation, not investment advice.